Blimp-1 (CT) Blocking Peptide

Blimp-1 (CT) Blocking Peptide

Product No.: B508

[product_table name="All Top" skus="B508"]

- -
- -
Target
Blimp-1
Product Type
Blocking Peptide
Alternate Names
B-Lymphocyte-Induced Maturation Protein 1, PR Domain-Containing Protein 1, PRDI-Binding Factor 1, PRDI-BF1

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
14 amino acids near the carboxy terminus of human Blimp-1.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Amino Acid Sequence
14 amino acids near the carboxy terminus of human Blimp-1.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Background
Blimp-1 peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

Antigen Details

References & Citations

1. Turner CAJ, Mack DH, and Davis MM. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B-lymphocytes into immunoglobulin-secreting cells. Cell 1994; 77:297-306.
Products are for research use only. Not for use in diagnostic or therapeutic procedures.